https://stock.noler.com/us/stock/globeimmune-inc https://stock.noler.com/us/stock/globeimmune-inc/accounts-payable https://stock.noler.com/us/stock/globeimmune-inc/accrued-income-taxes https://stock.noler.com/us/stock/globeimmune-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/globeimmune-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/globeimmune-inc/accrued-liabilities-current https://stock.noler.com/us/stock/globeimmune-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/globeimmune-inc/accrued-vacation-current https://stock.noler.com/us/stock/globeimmune-inc/accumulated-depreciation https://stock.noler.com/us/stock/globeimmune-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/globeimmune-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/globeimmune-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/globeimmune-inc/advance-royalties https://stock.noler.com/us/stock/globeimmune-inc/amended-reports-10-k https://stock.noler.com/us/stock/globeimmune-inc/amended-reports-10-q https://stock.noler.com/us/stock/globeimmune-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/globeimmune-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/globeimmune-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/globeimmune-inc/basic-shares https://stock.noler.com/us/stock/globeimmune-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/globeimmune-inc/capital-expenditures https://stock.noler.com/us/stock/globeimmune-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/globeimmune-inc/cash-and-equivalents https://stock.noler.com/us/stock/globeimmune-inc/cash-flow-breakdown https://stock.noler.com/us/stock/globeimmune-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/globeimmune-inc/common-stock-value https://stock.noler.com/us/stock/globeimmune-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/globeimmune-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/globeimmune-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/globeimmune-inc/cost-of-services-licenses-and-services https://stock.noler.com/us/stock/globeimmune-inc/costs-and-expenses https://stock.noler.com/us/stock/globeimmune-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/globeimmune-inc/current-assets https://stock.noler.com/us/stock/globeimmune-inc/current-liabilities https://stock.noler.com/us/stock/globeimmune-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/globeimmune-inc/deferred-revenue https://stock.noler.com/us/stock/globeimmune-inc/deferred-revenue-2 https://stock.noler.com/us/stock/globeimmune-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/globeimmune-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/globeimmune-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/globeimmune-inc/depreciation https://stock.noler.com/us/stock/globeimmune-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/globeimmune-inc/derivative-liabilities https://stock.noler.com/us/stock/globeimmune-inc/derivative-liabilities-current https://stock.noler.com/us/stock/globeimmune-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/globeimmune-inc/diluted-earnings-per-share-pro-forma https://stock.noler.com/us/stock/globeimmune-inc/diluted-shares https://stock.noler.com/us/stock/globeimmune-inc/dividends-preferred-stock-stock https://stock.noler.com/us/stock/globeimmune-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/globeimmune-inc/effective-tax-rate https://stock.noler.com/us/stock/globeimmune-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/globeimmune-inc/eps https://stock.noler.com/us/stock/globeimmune-inc/eps-basic https://stock.noler.com/us/stock/globeimmune-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/globeimmune-inc/form-d-other https://stock.noler.com/us/stock/globeimmune-inc/form-d-stocks https://stock.noler.com/us/stock/globeimmune-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/globeimmune-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/globeimmune-inc/general-and-administrative-expense https://stock.noler.com/us/stock/globeimmune-inc/income-loss-from https://stock.noler.com/us/stock/globeimmune-inc/income-tax https://stock.noler.com/us/stock/globeimmune-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/globeimmune-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/globeimmune-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/globeimmune-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/globeimmune-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/globeimmune-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/globeimmune-inc/insider-transactions-preferred https://stock.noler.com/us/stock/globeimmune-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/globeimmune-inc/insider-transactions-warrants https://stock.noler.com/us/stock/globeimmune-inc/interest-expense https://stock.noler.com/us/stock/globeimmune-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/globeimmune-inc/lease-and-rental-expense https://stock.noler.com/us/stock/globeimmune-inc/license-and-services-revenue https://stock.noler.com/us/stock/globeimmune-inc/manufacturing-costs https://stock.noler.com/us/stock/globeimmune-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/globeimmune-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/globeimmune-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/globeimmune-inc/net-change-in-cash https://stock.noler.com/us/stock/globeimmune-inc/net-income https://stock.noler.com/us/stock/globeimmune-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/globeimmune-inc/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/globeimmune-inc/number-of-operating-segments https://stock.noler.com/us/stock/globeimmune-inc/operating-cash-flow https://stock.noler.com/us/stock/globeimmune-inc/operating-expenses https://stock.noler.com/us/stock/globeimmune-inc/operating-income https://stock.noler.com/us/stock/globeimmune-inc/operating-lease-payments-due https://stock.noler.com/us/stock/globeimmune-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/globeimmune-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/globeimmune-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/globeimmune-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/globeimmune-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/globeimmune-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/globeimmune-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/globeimmune-inc/other-current-assets https://stock.noler.com/us/stock/globeimmune-inc/other-income https://stock.noler.com/us/stock/globeimmune-inc/other-liabilities https://stock.noler.com/us/stock/globeimmune-inc/other-noncurrent-assets https://stock.noler.com/us/stock/globeimmune-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/globeimmune-inc/other-nonoperating-income https://stock.noler.com/us/stock/globeimmune-inc/other-sales-revenue-net https://stock.noler.com/us/stock/globeimmune-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/globeimmune-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/globeimmune-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/globeimmune-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/globeimmune-inc/preferred-shares-facts https://stock.noler.com/us/stock/globeimmune-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/globeimmune-inc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/globeimmune-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/globeimmune-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/globeimmune-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/globeimmune-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/globeimmune-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/globeimmune-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/globeimmune-inc/pro-forma-weighted-average-shares-outstanding-diluted https://stock.noler.com/us/stock/globeimmune-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/globeimmune-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/globeimmune-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/globeimmune-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/globeimmune-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/globeimmune-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/globeimmune-inc/property-plant-equipment https://stock.noler.com/us/stock/globeimmune-inc/public-float https://stock.noler.com/us/stock/globeimmune-inc/research-and-development https://stock.noler.com/us/stock/globeimmune-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/globeimmune-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/globeimmune-inc/retained-earnings https://stock.noler.com/us/stock/globeimmune-inc/revenue https://stock.noler.com/us/stock/globeimmune-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/globeimmune-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/globeimmune-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-10-k https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-10-q https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-15-12b https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-25 https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-8-k https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-certnas https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-ct-order https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-def-14a https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-defa14a https://stock.noler.com/us/stock/globeimmune-inc/sec-filings-regdex https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/globeimmune-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/globeimmune-inc/security-deposit https://stock.noler.com/us/stock/globeimmune-inc/shareholders-equity https://stock.noler.com/us/stock/globeimmune-inc/shares-authorized https://stock.noler.com/us/stock/globeimmune-inc/shares-issued https://stock.noler.com/us/stock/globeimmune-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/globeimmune-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/globeimmune-inc/stock-based-compensation https://stock.noler.com/us/stock/globeimmune-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/globeimmune-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/globeimmune-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/globeimmune-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/globeimmune-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/globeimmune-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/globeimmune-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/globeimmune-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/globeimmune-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/globeimmune-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/globeimmune-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/globeimmune-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/globeimmune-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/globeimmune-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/globeimmune-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/globeimmune-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/globeimmune-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/globeimmune-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/globeimmune-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/globeimmune-inc/total-assets https://stock.noler.com/us/stock/globeimmune-inc/total-liabilities https://stock.noler.com/us/stock/globeimmune-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/globeimmune-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/globeimmune-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/globeimmune-inc/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/globeimmune-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/globeimmune-inc/weighted-average-number-of-share-outstanding-basic-and-diluted